Logo image of SYK

STRYKER CORP (SYK) Stock Fundamental Analysis

NYSE:SYK - US8636671013 - Common Stock

394.22 USD
+9.39 (+2.44%)
Last: 8/22/2025, 8:04:00 PM
394.22 USD
0 (0%)
After Hours: 8/22/2025, 8:04:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SYK. SYK was compared to 185 industry peers in the Health Care Equipment & Supplies industry. SYK has an excellent profitability rating, but there are some minor concerns on its financial health. SYK is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year SYK was profitable.
In the past year SYK had a positive cash flow from operations.
Each year in the past 5 years SYK has been profitable.
Each year in the past 5 years SYK had a positive operating cash flow.
SYK Yearly Net Income VS EBIT VS OCF VS FCFSYK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

1.2 Ratios

Looking at the Return On Assets, with a value of 6.30%, SYK belongs to the top of the industry, outperforming 84.49% of the companies in the same industry.
SYK has a Return On Equity of 13.77%. This is amongst the best in the industry. SYK outperforms 89.84% of its industry peers.
SYK has a better Return On Invested Capital (11.66%) than 91.98% of its industry peers.
SYK had an Average Return On Invested Capital over the past 3 years of 11.52%. This is above the industry average of 8.44%.
The 3 year average ROIC (11.52%) for SYK is below the current ROIC(11.66%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.3%
ROE 13.77%
ROIC 11.66%
ROA(3y)7.1%
ROA(5y)6.34%
ROE(3y)15.24%
ROE(5y)14.27%
ROIC(3y)11.52%
ROIC(5y)10.61%
SYK Yearly ROA, ROE, ROICSYK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 12.25%, SYK belongs to the top of the industry, outperforming 87.70% of the companies in the same industry.
SYK's Profit Margin has been stable in the last couple of years.
SYK has a Operating Margin of 22.25%. This is amongst the best in the industry. SYK outperforms 93.05% of its industry peers.
SYK's Operating Margin has been stable in the last couple of years.
With a decent Gross Margin value of 64.62%, SYK is doing good in the industry, outperforming 67.91% of the companies in the same industry.
SYK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.25%
PM (TTM) 12.25%
GM 64.62%
OM growth 3Y2.95%
OM growth 5Y0.05%
PM growth 3Y4.36%
PM growth 5Y-1.09%
GM growth 3Y-0.02%
GM growth 5Y-0.35%
SYK Yearly Profit, Operating, Gross MarginsSYK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

SYK has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SYK has more shares outstanding than it did 1 year ago.
SYK has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SYK has been reduced compared to a year ago.
SYK Yearly Shares OutstandingSYK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
SYK Yearly Total Debt VS Total AssetsSYK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

SYK has a debt to FCF ratio of 3.69. This is a good value and a sign of high solvency as SYK would need 3.69 years to pay back of all of its debts.
SYK's Debt to FCF ratio of 3.69 is amongst the best of the industry. SYK outperforms 84.49% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that SYK is somewhat dependend on debt financing.
The Debt to Equity ratio of SYK (0.70) is worse than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 3.69
Altman-Z N/A
ROIC/WACC1.39
WACC8.39%
SYK Yearly LT Debt VS Equity VS FCFSYK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.78 indicates that SYK should not have too much problems paying its short term obligations.
SYK has a Current ratio of 1.78. This is in the lower half of the industry: SYK underperforms 68.98% of its industry peers.
SYK has a Quick Ratio of 1.06. This is a normal value and indicates that SYK is financially healthy and should not expect problems in meeting its short term obligations.
SYK has a worse Quick ratio (1.06) than 74.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.06
SYK Yearly Current Assets VS Current LiabilitesSYK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.43% over the past year.
SYK shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.09% yearly.
Looking at the last year, SYK shows a quite strong growth in Revenue. The Revenue has grown by 11.36% in the last year.
SYK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.71% yearly.
EPS 1Y (TTM)14.43%
EPS 3Y10.28%
EPS 5Y8.09%
EPS Q2Q%11.39%
Revenue 1Y (TTM)11.36%
Revenue growth 3Y9.72%
Revenue growth 5Y8.71%
Sales Q2Q%11.07%

3.2 Future

Based on estimates for the next years, SYK will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.13% on average per year.
SYK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.40% yearly.
EPS Next Y11.79%
EPS Next 2Y11.28%
EPS Next 3Y11.14%
EPS Next 5Y10.13%
Revenue Next Year10.66%
Revenue Next 2Y9.58%
Revenue Next 3Y9.14%
Revenue Next 5Y8.4%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SYK Yearly Revenue VS EstimatesSYK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
SYK Yearly EPS VS EstimatesSYK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 30.68, SYK can be considered very expensive at the moment.
74.33% of the companies in the same industry are more expensive than SYK, based on the Price/Earnings ratio.
SYK is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.24, which is the current average of the S&P500 Index.
SYK is valuated quite expensively with a Price/Forward Earnings ratio of 26.11.
SYK's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SYK is cheaper than 73.80% of the companies in the same industry.
SYK's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.81.
Industry RankSector Rank
PE 30.68
Fwd PE 26.11
SYK Price Earnings VS Forward Price EarningsSYK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SYK is valued a bit cheaper than the industry average as 72.19% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, SYK is valued a bit cheaper than 78.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 37.45
EV/EBITDA 25.47
SYK Per share dataSYK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SYK does not grow enough to justify the current Price/Earnings ratio.
SYK has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.6
PEG (5Y)3.79
EPS Next 2Y11.28%
EPS Next 3Y11.14%

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.87%, SYK is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.74, SYK pays a better dividend. On top of this SYK pays more dividend than 92.51% of the companies listed in the same industry.
With a Dividend Yield of 0.87, SYK pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

The dividend of SYK is nicely growing with an annual growth rate of 9.03%!
SYK has been paying a dividend for at least 10 years, so it has a reliable track record.
SYK has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.03%
Div Incr Years15
Div Non Decr Years15
SYK Yearly Dividends per shareSYK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

SYK pays out 42.87% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of SYK is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP42.87%
EPS Next 2Y11.28%
EPS Next 3Y11.14%
SYK Yearly Income VS Free CF VS DividendSYK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
SYK Dividend Payout.SYK Dividend Payout, showing the Payout Ratio.SYK Dividend Payout.PayoutRetained Earnings

STRYKER CORP

NYSE:SYK (8/22/2025, 8:04:00 PM)

After market: 394.22 0 (0%)

394.22

+9.39 (+2.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners80.8%
Inst Owner Change0.39%
Ins Owners0.11%
Ins Owner Change3.74%
Market Cap150.71B
Analysts80
Price Target442.41 (12.22%)
Short Float %1.36%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend3.2
Dividend Growth(5Y)9.03%
DP42.87%
Div Incr Years15
Div Non Decr Years15
Ex-Date09-30 2025-09-30 (0.84)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.6%
Min EPS beat(2)1.01%
Max EPS beat(2)4.19%
EPS beat(4)4
Avg EPS beat(4)2.56%
Min EPS beat(4)1.01%
Max EPS beat(4)4.19%
EPS beat(8)7
Avg EPS beat(8)2.5%
EPS beat(12)10
Avg EPS beat(12)2.53%
EPS beat(16)11
Avg EPS beat(16)1.4%
Revenue beat(2)2
Avg Revenue beat(2)1.18%
Min Revenue beat(2)0.53%
Max Revenue beat(2)1.82%
Revenue beat(4)4
Avg Revenue beat(4)0.94%
Min Revenue beat(4)0.17%
Max Revenue beat(4)1.82%
Revenue beat(8)6
Avg Revenue beat(8)0.94%
Revenue beat(12)9
Avg Revenue beat(12)1.43%
Revenue beat(16)11
Avg Revenue beat(16)0.87%
PT rev (1m)1.61%
PT rev (3m)1.15%
EPS NQ rev (1m)0.19%
EPS NQ rev (3m)-2.68%
EPS NY rev (1m)1.08%
EPS NY rev (3m)1.13%
Revenue NQ rev (1m)1.06%
Revenue NQ rev (3m)1.82%
Revenue NY rev (1m)0.92%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 30.68
Fwd PE 26.11
P/S 6.33
P/FCF 37.45
P/OCF 31.62
P/B 7.11
P/tB N/A
EV/EBITDA 25.47
EPS(TTM)12.85
EY3.26%
EPS(NY)15.1
Fwd EY3.83%
FCF(TTM)10.53
FCFY2.67%
OCF(TTM)12.47
OCFY3.16%
SpS62.3
BVpS55.43
TBVpS-10.34
PEG (NY)2.6
PEG (5Y)3.79
Profitability
Industry RankSector Rank
ROA 6.3%
ROE 13.77%
ROCE 13.57%
ROIC 11.66%
ROICexc 12.45%
ROICexgc 39.83%
OM 22.25%
PM (TTM) 12.25%
GM 64.62%
FCFM 16.89%
ROA(3y)7.1%
ROA(5y)6.34%
ROE(3y)15.24%
ROE(5y)14.27%
ROIC(3y)11.52%
ROIC(5y)10.61%
ROICexc(3y)12.76%
ROICexc(5y)11.78%
ROICexgc(3y)39.46%
ROICexgc(5y)36.43%
ROCE(3y)13.4%
ROCE(5y)12.35%
ROICexcg growth 3Y8.12%
ROICexcg growth 5Y2.91%
ROICexc growth 3Y8.12%
ROICexc growth 5Y1.03%
OM growth 3Y2.95%
OM growth 5Y0.05%
PM growth 3Y4.36%
PM growth 5Y-1.09%
GM growth 3Y-0.02%
GM growth 5Y-0.35%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 3.69
Debt/EBITDA 2.32
Cap/Depr 67.45%
Cap/Sales 3.12%
Interest Coverage 250
Cash Conversion 74.48%
Profit Quality 137.9%
Current Ratio 1.78
Quick Ratio 1.06
Altman-Z N/A
F-Score5
WACC8.39%
ROIC/WACC1.39
Cap/Depr(3y)62.25%
Cap/Depr(5y)59.95%
Cap/Sales(3y)3.11%
Cap/Sales(5y)3.16%
Profit Quality(3y)100.64%
Profit Quality(5y)122.75%
High Growth Momentum
Growth
EPS 1Y (TTM)14.43%
EPS 3Y10.28%
EPS 5Y8.09%
EPS Q2Q%11.39%
EPS Next Y11.79%
EPS Next 2Y11.28%
EPS Next 3Y11.14%
EPS Next 5Y10.13%
Revenue 1Y (TTM)11.36%
Revenue growth 3Y9.72%
Revenue growth 5Y8.71%
Sales Q2Q%11.07%
Revenue Next Year10.66%
Revenue Next 2Y9.58%
Revenue Next 3Y9.14%
Revenue Next 5Y8.4%
EBIT growth 1Y13.91%
EBIT growth 3Y12.96%
EBIT growth 5Y8.77%
EBIT Next Year26.46%
EBIT Next 3Y15.12%
EBIT Next 5Y13.72%
FCF growth 1Y66.49%
FCF growth 3Y8.39%
FCF growth 5Y17.73%
OCF growth 1Y57.55%
OCF growth 3Y9.14%
OCF growth 5Y14.13%